Bone Other Cashflows From Financing Activities from 2010 to 2025

BBLGW Stock  USD 15.00  0.00  0.00%   
Bone Biologics Other Cashflows From Financing Activities yearly trend continues to be fairly stable with very little volatility. Other Cashflows From Financing Activities is likely to outpace its year average in 2025. During the period from 2010 to 2025, Bone Biologics Other Cashflows From Financing Activities regression line of quarterly data had r-squared of  0.14 and coefficient of variation of  111.39. View All Fundamentals
 
Other Cashflows From Financing Activities  
First Reported
2008-03-31
Previous Quarter
M
Current Value
347.5 K
Quarterly Volatility
1.8 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bone Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bone Biologics' main balance sheet or income statement drivers, such as Other Operating Expenses of 4.1 M, Total Operating Expenses of 4.7 M or Gross Profit of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.3 or PTB Ratio of 2.58. Bone financial statements analysis is a perfect complement when working with Bone Biologics Valuation or Volatility modules.
  
Build AI portfolio with Bone Stock
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Latest Bone Biologics' Other Cashflows From Financing Activities Growth Pattern

Below is the plot of the Other Cashflows From Financing Activities of Bone Biologics Corp over the last few years. It is Bone Biologics' Other Cashflows From Financing Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bone Biologics' overall financial position and show how it may be relating to other accounts over time.
Other Cashflows From Financing Activities10 Years Trend
Slightly volatile
   Other Cashflows From Financing Activities   
       Timeline  

Bone Other Cashflows From Financing Activities Regression Statistics

Arithmetic Mean2,026,711
Coefficient Of Variation111.39
Mean Deviation1,955,430
Median1,250,000
Standard Deviation2,257,535
Sample Variance5.1T
Range6.3M
R-Value0.38
Mean Square Error4.7T
R-Squared0.14
Significance0.15
Slope178,535
Total Sum of Squares76.4T

Bone Other Cashflows From Financing Activities History

20255.3 M
2024M
2023 5044.16
2022 4429.86
20211.1 M
2020805.6 K
20194.6 M

About Bone Biologics Financial Statements

Bone Biologics investors use historical fundamental indicators, such as Bone Biologics' Other Cashflows From Financing Activities, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bone Biologics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Cashflows From Financing ActivitiesM5.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bone Stock Analysis

When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.